Researchers have identified a blood profile that could help identify COVID-19 patients at greatest risk of deterioration and direct them towards trials of specific treatments that could modify their immune systems' responses

New research identifies how immune activation with checkpoint inhibitors can sometimes lead to rapidly progressive tuberculosis